08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
The recent case of PBS Energo A.S v Bester Generacion UK Ltd [2020] EWHC 223 (TCC) provides a remind...
Read More >
In Kudsk Construction Inc. v. The United States, No. 18-1032C (August 30, 2019), the Court of Federa...
Read More >
As a 401(k) plan sponsor, you need to know that plan errors happen all the time. A 401(k) plan has s...
Read More >
On September 17, the US Department of the Treasury issued comprehensive proposed regulations to impl...
Read More >
Delaware courts have established rules of construction for interpreting insurance policies. Among th...
Read More >
Seyfarth Synopsis: The Trump Administration has succeeded in replacing several open positions withi...
Read More >